Fosun Pharma posted a loss in its first day of trading in Hong Kong, falling 8% from its IPO price to close at HK$10.84 (US$1.40). It hit an intraday low of HK$10.38. The IPO was priced HK$11.80, the low end of the range, which put the H-shares at a 13% discount from the Shanghai-listed price. The company’s stock may do better in the rest of the week. After the markets closed, Fosun reported its Q3 net income rose 95% on a 27% increase in revenues. More details.... Stock Symbol: (SHA: 600196; HK: 2196) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});